Cancer Family
Neuroendocrine Neoplasm
CI-CAN-00000286NENExplore in graph →
Non-malignant698 active trials12 approved drugs34 evidence items
- NCIt
- C3809
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000286NENExplore in graph →
Clinical trials
2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05359146 | Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)(Beta plus) | unknown | Early Phase 1 | 16 | University Hospital, Basel, SwitzerlandOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04897542 | Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors | unknown | Early Phase 1 | 100 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 |
| Sep 18, 2023 |
| clinicaltrials |
| NCT05886075 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | unknown | Early Phase 1 | 24 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Jun 2, 2023 | clinicaltrials |
| NCT05034783 | [68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients | unknown | Early Phase 1 | 20 | Peking Union Medical College HospitalOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT02817945 | Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT02823691 | The MetNET-2 Trial(MetNET-2) | unknown | Early Phase 1 | 20 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jun 7, 2021 | clinicaltrials |
| NCT04185350 | Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma | unknown | Early Phase 1 | 60 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Dec 4, 2019 | clinicaltrials |
| NCT04041882 | 68Ga-DOTATATE PET/CT in Neuroendocrine Tumor | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Aug 1, 2019 | clinicaltrials |
| NCT02560376 | 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Sep 25, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Apr 19, 2024source: clinicaltrials